Is 300753 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 300753 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 300753 (CN¥17.42) is trading above our estimate of fair value (CN¥0.94)
Significantly Below Fair Value: 300753 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 300753?
Key metric: As 300753 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for 300753. This is calculated by dividing 300753's market cap by their current
revenue.
What is 300753's PS Ratio?
PS Ratio
5.5x
Sales
CN¥401.11m
Market Cap
CN¥2.20b
300753 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: 300753 is good value based on its Price-To-Sales Ratio (5.5x) compared to the CN Medical Equipment industry average (6.7x).
Price to Sales Ratio vs Fair Ratio
What is 300753's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
300753 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
5.5x
Fair PS Ratio
n/a
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 300753's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.